JASPER THERAPEUTICS INC - COM (JSPR)

CUSIP: 471871103

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COM
Total 13F shares
15,061,259
Share change
+1,519,047
Total reported value
$114,706,000
Put/Call ratio
14%
Price per share
$7.84
Number of holders
21
Value change
+$11,794,672
Number of buys
16
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 471871103?
CUSIP 471871103 identifies JSPR - JASPER THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of JASPER THERAPEUTICS INC - COM (JSPR) as of Q4 2021

As of 31 Dec 2021, JASPER THERAPEUTICS INC - COM (JSPR) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,061,259 shares. The largest 10 holders included Abingworth LLP, Velan Capital Investment Management LP, CITADEL ADVISORS LLC, FEDERATED HERMES, INC., KINGDON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, MORGAN STANLEY, Grace Capital, BlackRock Inc., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.